| License: Creative Commons Attribution Non-commercial 4.0 PDF - Published Version (274kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-445990
- DOI to cite this document:
- 10.5283/epub.44599
This publication is part of the DEAL contract with Wiley.
Abstract
In addition to approved indications in non-melanoma skin cancer in immunocompetent patients, topical photodynamic therapy (PDT) has also been studied for its place in the treatment of, as well as its potential to prevent, superficial skin cancers in immune-suppressed patients, although sustained clearance rates are lower than for immune-competent individuals. PDT using a nanoemulsion of ALA in a ...
Owner only: item control page